• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对人一氧化氮合酶的强效和选择性抑制。非氨基酸异硫脲的抑制作用。

Potent and selective inhibition of human nitric oxide synthases. Inhibition by non-amino acid isothioureas.

作者信息

Garvey E P, Oplinger J A, Tanoury G J, Sherman P A, Fowler M, Marshall S, Harmon M F, Paith J E, Furfine E S

机构信息

Wellcome Research Laboratories, Research Triangle Park, North Carolina 27709.

出版信息

J Biol Chem. 1994 Oct 28;269(43):26669-76.

PMID:7523409
Abstract

S-Ethylisothiourea was a potent competitive inhibitor of human nitric oxide synthase (NOS), with Ki values of 17, 36, and 29 nM for the inducible (i), endothelial (e), and neuronal (n) isozymes, respectively. Unlike some potent inhibitors of NOS, no time dependence was observed. S-Ethylisothiourea was not a detectable substrate for eNOS. S-Ethylisothiourea was also a potent inhibitor of mouse iNOS (Ki value of 5.2 nM), and its binding perturbed the spectrum of iNOS consistent with its altering the environment of the bound heme. The optimum binding of S-ethyl- and S-isopropylisothiourea relative to 70 other analogs suggested that these alkyl substitutions fit into a small hydrophobic pocket. Most isothioureas were 2-6-fold selective for the human iNOS (Ki for iNOS versus Ki for eNOS), with one being 19-fold selective. The cyclized mimics of S-ethylisothiourea, 2-NH2-thiazoline, and 2-NH2-thiazole, were also competitive inhibitors of human NOS. A third structural class of inhibitors, bisisothioureas, were, in general, the most selective in their inhibition of human iNOS. S,S'-(1,3-Phenylenebis(1,2-ethanediyl))bisisothiourea was 190-fold selective (Ki value of 0.047 microM against iNOS versus 9.0 microM against eNOS). These results demonstrate that potent and selective inhibition of human NOS isozymes is achievable.

摘要

S - 乙基异硫脲是一种强效的人一氧化氮合酶(NOS)竞争性抑制剂,对诱导型(i)、内皮型(e)和神经元型(n)同工酶的Ki值分别为17、36和29 nM。与一些强效的NOS抑制剂不同,未观察到时间依赖性。S - 乙基异硫脲不是可检测到的内皮型一氧化氮合酶(eNOS)底物。S - 乙基异硫脲也是小鼠诱导型一氧化氮合酶(iNOS)的强效抑制剂(Ki值为5.2 nM),其结合使iNOS的光谱发生扰动,这与其改变结合血红素的环境一致。相对于其他70种类似物,S - 乙基和S - 异丙基异硫脲的最佳结合表明这些烷基取代基适合一个小的疏水口袋。大多数异硫脲对人诱导型一氧化氮合酶具有2 - 6倍的选择性(诱导型一氧化氮合酶的Ki值与内皮型一氧化氮合酶的Ki值相比),其中一种具有19倍的选择性。S - 乙基异硫脲的环化模拟物2 - NH₂ - 噻唑啉和2 - NH₂ - 噻唑也是人一氧化氮合酶的竞争性抑制剂。第三类结构抑制剂双异硫脲通常在抑制人诱导型一氧化氮合酶方面最具选择性。S,S' - (1,3 - 亚苯基双(1,2 - 乙二基))双异硫脲具有190倍的选择性(对诱导型一氧化氮合酶的Ki值为0.047 μM,对内皮型一氧化氮合酶的Ki值为9.0 μM)。这些结果表明,可以实现对人一氧化氮合酶同工酶的强效和选择性抑制。

相似文献

1
Potent and selective inhibition of human nitric oxide synthases. Inhibition by non-amino acid isothioureas.对人一氧化氮合酶的强效和选择性抑制。非氨基酸异硫脲的抑制作用。
J Biol Chem. 1994 Oct 28;269(43):26669-76.
2
Isothioureas: potent inhibitors of nitric oxide synthases with variable isoform selectivity.异硫脲:一氧化氮合酶的强效抑制剂,具有可变的同工型选择性。
Br J Pharmacol. 1995 Jan;114(2):510-6. doi: 10.1111/j.1476-5381.1995.tb13256.x.
3
Potent and selective inhibition of human nitric oxide synthases. Selective inhibition of neuronal nitric oxide synthase by S-methyl-L-thiocitrulline and S-ethyl-L-thiocitrulline.对人一氧化氮合酶的强效和选择性抑制。S-甲基-L-硫代瓜氨酸和S-乙基-L-硫代瓜氨酸对神经元一氧化氮合酶的选择性抑制。
J Biol Chem. 1994 Oct 28;269(43):26677-83.
4
Novel potent and selective inhibitors of inducible nitric oxide synthase.新型高效且选择性诱导型一氧化氮合酶抑制剂
Mol Pharmacol. 1995 Apr;47(4):831-4.
5
N-nitro-L-arginine and N-monomethyl-L-arginine exhibit a different pattern of inactivation toward the three nitric oxide synthases.N-硝基-L-精氨酸和N-单甲基-L-精氨酸对三种一氧化氮合酶表现出不同的失活模式。
Arch Biochem Biophys. 1995 Jun 20;320(1):170-6. doi: 10.1006/abbi.1995.1356.
6
Beneficial effects and improved survival in rodent models of septic shock with S-methylisothiourea sulfate, a potent and selective inhibitor of inducible nitric oxide synthase.硫酸S-甲基异硫脲(一种诱导型一氧化氮合酶的强效选择性抑制剂)在脓毒性休克啮齿动物模型中的有益作用及生存改善情况。
Proc Natl Acad Sci U S A. 1994 Dec 20;91(26):12472-6. doi: 10.1073/pnas.91.26.12472.
7
Mapping the active site polarity in structures of endothelial nitric oxide synthase heme domain complexed with isothioureas.
J Inorg Biochem. 2000 Aug 31;81(3):133-9. doi: 10.1016/s0162-0134(00)00099-4.
8
Certain S-substituted isothioureas not only inhibit NO synthase catalytic activity but also decrease translation and stability of inducible NO synthase protein.
Nitric Oxide. 1998;2(3):155-64. doi: 10.1006/niox.1998.0171.
9
Spontaneous rearrangement of aminoalkylisothioureas into mercaptoalkylguanidines, a novel class of nitric oxide synthase inhibitors with selectivity towards the inducible isoform.氨基烷基异硫脲自发重排为巯基烷基胍,这是一类对诱导型同工酶具有选择性的新型一氧化氮合酶抑制剂。
Br J Pharmacol. 1996 Feb;117(4):619-32. doi: 10.1111/j.1476-5381.1996.tb15236.x.
10
Pharmacological characterization of guanidinoethyldisulphide (GED), a novel inhibitor of nitric oxide synthase with selectivity towards the inducible isoform.胍基乙基二硫化物(GED)的药理学特性,一种对诱导型一氧化氮合酶具有选择性的新型一氧化氮合酶抑制剂。
Br J Pharmacol. 1996 Aug;118(7):1659-68. doi: 10.1111/j.1476-5381.1996.tb15589.x.

引用本文的文献

1
Red blood cell eNOS is cardioprotective in acute myocardial infarction.红细胞内皮型一氧化氮合酶在急性心肌梗死中具有心脏保护作用。
Redox Biol. 2022 Aug;54:102370. doi: 10.1016/j.redox.2022.102370. Epub 2022 Jun 18.
2
Human Nitric Oxide Synthase-Its Functions, Polymorphisms, and Inhibitors in the Context of Inflammation, Diabetes and Cardiovascular Diseases.人一氧化氮合酶-在炎症、糖尿病和心血管疾病背景下的功能、多态性和抑制剂。
Int J Mol Sci. 2020 Dec 23;22(1):56. doi: 10.3390/ijms22010056.
3
IGF1R and MAPK15 Emerge as Potential Targets of Pentabromobenzylisothioureas in Lung Neuroendocrine Neoplasms.
胰岛素样生长因子1受体(IGF1R)和丝裂原活化蛋白激酶15(MAPK15)成为五溴苄基异硫脲在肺神经内分泌肿瘤中的潜在靶点。
Pharmaceuticals (Basel). 2020 Oct 29;13(11):354. doi: 10.3390/ph13110354.
4
Development and Clinical Application of Phosphorus-Containing Drugs.含磷药物的研发与临床应用
Med Drug Discov. 2020 Dec;8:100063. doi: 10.1016/j.medidd.2020.100063. Epub 2020 Aug 25.
5
Nitric Oxide Synthase Inhibitors into the Clinic at Last.终于将一氧化氮合酶抑制剂推向临床。
Handb Exp Pharmacol. 2021;264:169-204. doi: 10.1007/164_2020_382.
6
iNOS-inhibitor driven neuroprotection in a porcine retina organ culture model.iNOS 抑制剂诱导的猪视网膜器官培养模型中的神经保护作用。
J Cell Mol Med. 2020 Apr;24(7):4312-4323. doi: 10.1111/jcmm.15091. Epub 2020 Mar 4.
7
Isothioureas, Ureas, and Their -Methyl Amides from 2-Aminobenzothiazole and Chiral Amino Acids.2-氨基苯并噻唑与手性氨基酸的异硫脲、脲及其 - 甲基酰胺。
Molecules. 2019 Sep 18;24(18):3391. doi: 10.3390/molecules24183391.
8
Inducible nitric oxide synthase: Regulation, structure, and inhibition.诱导型一氧化氮合酶:调控、结构与抑制。
Med Res Rev. 2020 Jan;40(1):158-189. doi: 10.1002/med.21599. Epub 2019 Jun 13.
9
Nitric Oxide Synthase Inhibitors as Antidepressants.一氧化氮合酶抑制剂作为抗抑郁药
Pharmaceuticals (Basel). 2010 Jan 20;3(1):273-299. doi: 10.3390/ph3010273.
10
The role of iNOS in cholesterol-induced liver fibrosis.诱导型一氧化氮合酶在胆固醇诱导的肝纤维化中的作用。
Lab Invest. 2015 Aug;95(8):914-24. doi: 10.1038/labinvest.2015.67. Epub 2015 Jun 22.